After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

Amgen (Nasdaq: AMGN) has completed construction of a $550 million drug manufacturing facility in the Wake County town.

Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

With a ribbon cutting at one facility and a groundbreaking for another Friday, Amgen takes another concrete step towards a ...

Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the ...

Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

In an industry-defining moment, Accumulus Synergy (“Accumulus”) has powered Amgen’s groundbreaking regulatory submission: the ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

My name is Julianne, and I will be your conference facilitator today for Amgen's fourth quarter and full year 2024 financial results conference call. (Operator Instructions) I would now like to ...